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HIGHLIGHTS 
•	 The viper snake venom is mostly blood-oriented and leads to blood coagulation.
•	 The snakes venom, including vipers venom endemic of Iran could be applied for pharmaceutical purposes.
•	  A 26KD protein was the most effective component of viper venom showed plasma coagulation.
•	  The results showed this protein was related to serine protease enzyme of snake venom.
The venom of the viper is very important in pharmaceutical usage, such as in the process 
of coagulation during medical care. This study aims to evaluate the coagulant factor of 
Latifi and Zanjani viper venom. In the current study, after electrophoresis of proteins 
found in viper venom, all of the thick and strong bands of proteins were isolated and 
prepared for examination of coagulation characteristics, like pro-thrombin time (PTT) 
and active partial thromboplastic time (APTT), followed by further study by mass 
spectroscopy. In this way, 11 bands of proteins were recognized in sodium dodecyl 
sulphate polyacrylamide gel electrophoresis (SDS-PAGE). After PT and APTT tests, one 
common band in 26 KDa could lead to coagulation of blood plasma in less than one 
second. Mass spectroscopy identified this band as serine protease isoform4. The results 
confirmed the coagulation effect of a 26 KDa protein fraction of venom from Latifi and 
Zanjani vipers.
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Introduction
Snakes are peculiar animals as their exact origins remain 
unknown. Studies on these species focus especially on 
their venom in order to produce an effective recombinant 
toxic factor. To achieve the therapeutic goal and design its 
recombinant type using a biotechnology approach, first, 
the coagulant factor of viper venom should be recognized 
(Boyot et al., 1990; Matsui et al., 2000; Clement et al., 
2012). Viper venom is mostly blood-oriented. It leads to 
blood coagulation and, consequently, death of the victim. 
The main signs of a viper bite are inflammation, local pain 
along with tissue decay, and organ failure. The venom of 
a viper causes pain, inflammation, and blushing of skin. 
Sometimes, it leads to blisters, with plasma and superficial 
discharges that develop slowly (Kornalík, 1985). Vipers 
are mostly found on the southern slopes of central Alborz 
(Rajabizadeh et al., 2012). The venom of this type of 
viper has a higher lethal factor than other similar types. 
So, stronger and more effective toxic factors are found in 
the venom of this type of viper.
Notably, the distance of extinguishment in Iranian 
viper snake is not endangered. Moreover, it is not unlikely 
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that indiscriminate harvesting before and after their 
discovery in 1346 brought them to this stage.
The use of snake venom—including the venom of 
vipers endemic in Iran—for a variety of pharmaceutical 
purposes, recently necessitated accurate and scientific 
research on the pharmacology products derived from 
these animals, since these creatures are now in danger of 
extinction. It is necessary to prevent over-hunting of these 
animals and improve their conservation by breeding them 
(Kool, 2016; Samy et al., 2016). 
The following study was conducted at the Cellular 
and Molecular Biology Research Center at the Shahid 
Beheshti University of Medical Sciences. The results 
confirmed the high quality of Latifi viper venom. To 
achieve the therapeutic goal and design its recombinant 
type using the biotechnology approach, first, in order 
to recognize the coagulant factor of viper venom, we 
analysed venom proteins using sodium dodecyl sulphate 
polyacrylamide gel electrophoresis (SDS-PAGE), pro-
thrombin time (PTT), activated partial thromboplastin 
time (APTT), Western blotting, and MOLDI-TOF mass 
spectroscopy. 
Material and Methods 
Preparing venom of snakes in captivity
The venom samples were obtained from 10 Latifi and 
Zanjani vipers resident in the laboratory of live animals 
of the College of Agriculture and Natural Resources at 
Tehran University. The sampling was performed twice 
within an interval of one month in the summer. The 
obtained venoms were transferred to the laboratory of the 
Cellular and Molecular Biology Research Center at the 
Shahid Beheshti University of Medical Sciences. 
Figure 1. Typical vertical gel electrophoresis of Latifi’s viper snake 
venom (right) and Zanjani’s viper snake venom (left).
Investigation of coagulation properties of 
components of snake venom
The venom samples were electrophoresed on 12% 
acrylamide gel at a voltage of 100V. After three hours, 11 
bands from Latifi viper venom and eight bands formed 
from Zanjani viper venom were separated. Then, each 
band was homogenized using 200µl sterilized PBS. After 
30 minutes, protein purification was carried out to remove 
the DNA and other debris using a Pierce SDS-PAGE 
Sample Prep Kit (Thermo Scientific, USA). 
Preparing blood plasma samples
The fresh blood samples with 0.11 M sodium citrate 
(Bahar Afshan, Iran) were collected and centrifuged with 
448 g for 10 minutes. The obtained plasma was transferred 
into clean test tubes.
Coagulation testing of PT assay
To perform the PT test, 50 µl of blood plasma was 
incubated in a 37°C water bath for three minutes. Then 
200µl of leukoplatin and 50µl of purified protein band 
were added to it. This test was performed separately for 
each purified protein band.
APTT assay 
Since the normal value of PTT was 60–70 seconds, 
which is a relatively long time, the APTT was also used 
for purified protein bands. To perform this test, 100µl of 
leucocephala was added to 50µl of blood plasma. This 
was then incubated in a 37°C water bath for three minutes. 
Next, 100µl of calcium chloride (CaCl2) and 50µl of 
purified protein of viper venom (Latifi and Zanjani) was 
added to it. This test was performed separately for each 
band. 
MS-MALDI-TOF spectroscopy of effective 
components of snake venom
The purified protein samples were digested with trypsin 
and the obtained peptides were studied using MOLDI-
TOF or TOF spectrometry. This part of the study was 
carried out in Proteomics International Pty Ltd Company, 
Australia. To analyse and identify isolated proteins, 
Mascot sequence matching software and the Ludwig NR 
database were used.
Results 
SDS-PAGE of Latifi and Zanjani viper venom
As shown in Figure 1, the protein bands of venom obtained 
from each viper were separated on SDS-PAGE.   
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Coagulation test of PT of Latifi and Zanjani viper 
venom
Subsequently, the coagulation effect of bands obtained 
from the electrophoresis of Latifi viper venom on blood 
as well as blood plasma was compared by a PT test. The 
bands 5, 6, and 8 (Fig. 1) obtained from the electrophoresis 
of Latifi viper venom led to blood clots at the time. In 
contrast, the blood plasma led to blood clots in these 
bands within 15 seconds. The reaction was carried out 
with bands 2, 3, 4, and 9 during 18 to 26 seconds by blood 
plasma. The coagulation effect of bands obtained from the 
electrophoresis of Zanjani viper venom on blood as well 
as blood plasma was compared by a PT test. The bands 
4, 5, and 6 obtained from the electrophoresis of Zanjani 
viper venom led to blood clots at the time. In contrast, the 
blood plasma formed blood clots with these bands within 
14 seconds. The reaction was carried out with bands 1, 2, 
3, 7 and 8 during 18 to 26 seconds on blood plasma.
Coagulation test of APTT of Latifi and Zanjani viper 
venom
The coagulation effect of bands obtained from the 
electrophoresis of Latifi viper venom on blood as well 
as blood plasma was also compared using APTT. This 
test showed results similar to those of the PT test. After 
determining the bands obtained from the electrophoresis 
of viper venom that caused rapid blood coagulation, the 
band 6 (26 KDa) was shown to be the most effective 
component of plasma coagulation. This band was sent to 
Proteomics International Pty Ltd Company for analysis 
using the MOLDI-TOF method. The results of the study 
showed that this protein was related to the serine protease 
enzyme of snake venom.
The effective component of snake venom  
The sharp protein band in 26 KDa could lead to 
coagulation of blood plasma in less than one second, as 
per analysis by MOLDI-TOF mass spectroscopy. The 
Mascot server showed that the purified protein was serine 
protease isoform4.
Discussion
The present study sought to evaluate the coagulant factor 
of viper venom endemic in Iran (Latifi and Zanjani) and 
as the fact of country’s biodiversity values in order to 
produce the recombinant type and prevent extinction. 
The three first bands in Zanjani viper venom gel 
electrophoresis were weaker than those in Latifi venom. 
These bands were omitted in further blood coagulation 
tests and the overall pattern of bands in Zanjani’s gel 
electrophoresis has been considered. Then the sharp and 
high-quality bands in gel were prepared from both Latifi 
and Zanjani’s gels, and the PT and APTT were carried 
out on separated protein bands. The results showed that 
three proteins of SDS-PAGE in two samples of Latifi and 
Zanjani viper venom have the coagulation effect.
A gel diffusion test was performed on the Zanjani 
and Latifi viper venom. The study was carried out with 
1/10, 1/100, and 1/1,000 poly-valan anti-snake bite 
antibody dilutions (Razi Institute, Iran), which showed 
there was substantial antigenic similarity between the 
two venom samples. The venom of baby vipers had a 
similar response and the precipitation of the presence of 
antigen with antisera was observed. But in the second 
group (Cerastescerastes and Zanjani vipers), there were 
no acceptable results with the different antibody dilutions 
(1/10, 1/100, 1/500, and 1/1,000) and snake venom 
samples.
In addition, in 1391, a master thesis entitled 
‘Evaluation of the quality of the endemic Latifi viper 
snake venom (Montivipera latifi)’, sought to provide a 
solution for maintenance in captivity to reduce hunting 
and enhance protection. This experiment showed that the 
venom of each species had the same quality and sharp 
bands. Although the sharpness of Latifi venom was 
stronger than Zanjani’s, the number of bands was equal. 
In the second step, Latifi viper venom was analysed thrice. 
Consequently, the results showed the higher quality of 
this venom (Pourazin et al., 2011). 
These two studies formed the basic research on the 
quality of viper venom. They also provided a comparison 
between the two. Moreover, the gel diffusion method 
in the first study evaluated the impact of the venom on 
antisera in different dilutions. 
The current study took one step forward and evaluated 
the coagulation property of Latifi and Zanjani viper 
venoms using SDS-PAGE. Following this, the PT and 
APTT tests were performed with the SDS-PAGE bands 
formed in two viper venom samples. 
In one research study conducted by Rajabizadeh 
et al. (2012) on the pattern of distribution of Latifi 
viper snakes with regard to diversity and gender 
differences, snake venom is quantitatively analysed 
using dimensional electrophoresis and High Performance 
Liquid Chromatography (HPLC). Meanwhile, this study 
was performed with a focus on quality, and the trials were 
carried out using SDS-PAGE and the Western blotting 
method. 
Toxicology experts in Egypt have studied 
Cerastescerastes venom to evaluate the detailed 
specifications in proteins using HPLC and SDS-PAGE 
(Wahby et al., 2012). 
Conclusion
After determining the bands obtained from the 
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electrophoresis of viper venom, which caused rapid blood 
coagulation, the 26 KDa protein was identified as the most 
effective component of plasma coagulation. After analysis 
by the MOLDI-TOF method, the obtained results revealed 
that this protein was related to the serine protease enzyme 
of snake venom.
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